Citation: Yh. Chai et al., The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease, J BIOL CHEM, 276(48), 2001, pp. 44889-44897
Citation: Hye. Chan et al., Mechanisms of chaperone suppression of polyglutamine disease: selectivity,synergy and medullation of protein solubility in Drosophila, HUM MOL GEN, 9(19), 2000, pp. 2811-2820
Citation: Jm. Warrick et al., Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70, NAT GENET, 23(4), 1999, pp. 425-428
Citation: Yh. Chai et al., Evidence for proteasome involvement in polyglutamine disease: localizationto nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro, HUM MOL GEN, 8(4), 1999, pp. 673-682
Citation: Mk. Perez et al., Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix, HUM MOL GEN, 8(13), 1999, pp. 2377-2385
Citation: Yh. Chai et al., Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease, J NEUROSC, 19(23), 1999, pp. 10338-10347
Citation: Hl. Paulson, Protein fate in neurodegenerative proteinopathies: Polyglutamine diseases join the (mis)fold, AM J HU GEN, 64(2), 1999, pp. 339-345
Citation: Mk. Perez et al., Recruitment and the role of nuclear localization in polyglutamine-mediatedaggregation, J CELL BIOL, 143(6), 1998, pp. 1457-1470